INDIANAPOLIS, June 24 (UPI) -- Eli Lilly and Co. says the U.S. Food and Drug Administration has extended the review period for the experimental blood thinner prasugrel.
INDIANAPOLIS, June 18 (UPI) -- Eli Lilly and Co. said the U.S. Food and Drug Administration has approved duloxetine HCl, marketed under the name Cymbalta, for fibromyalgia.
ANCHORAGE, Alaska, March 12 (UPI) -- A former U.S. drug regulator testified at a trial in Alaska Monday that Eli Lilly tried to minimize the negative aspects of the drug Zyprexa.
EVANSTON, Ill., June 4 (UPI) -- U.S. medical scientists believe they have discovered why people often suffer from life-altering chronic pain long after an injury has healed.
JACKSON, Miss., July 25 (UPI) -- Mississippi has filed a legal action against Eli Lilly and Co. alleging a plan to defraud the state of millions of dollars in Medicaid reimbursements.
INDIANAPOLIS, May 9 (UPI) -- Eli Lilly said Tuesday it has filed for approval of its antidepressant drug Cymbalta to treat generalized anxiety disorder.
INDIANAPOLIS, Dec. 22 (UPI) -- The Indianapolis-based Eli Lilly & Co. has reportedly agreed to pay a $36 million fine for off-label promotion of its Evista osteoporosis treatment.
INDIANAPOLIS, Jan. 13 (UPI) -- Eli Lilly & Co. is releasing documents to rebut a British Medical Journal charge the Indiana company hid data linking an antidepressant drug and suicide.
INDIANAPOLIS, May 8 (UPI) -- Eli Lilly and Co. Wednesday investigated suspected tampering involving its schizophrenia drug, Zyprexa, after several pharmacists in Minnesota and Wisconsin fou
WASHINGTON, March 5 (UPI) -- Eli Lilly and Co., one of the biggest pharmaceutical companies in the industry, Tuesday announced a program to offer low-income seniors a discount drug plan. It would allow seniors to purchase prescription drugs for $12 per prescription per month.
